Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

Mouse Models of Cancer Study

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

The Lancet. Oncology·2026

Same author

Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Nature·2026

Same author

A Legacy of Mentorship: A Tribute to Lewis Cantley.

Cancer discovery·2026

Same author

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.

The Journal of clinical investigation·2026

Same author

Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Cancer discovery·2026

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Modeling oncogene addiction using RNA interference.

S Michael Rothenberg¹, Jeffrey A Engelman, Sheila Le

¹Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, USA.

Proceedings of the National Academy of Sciences of the United States of America

|August 20, 2008

Summary

This summary is machine-generated.

Cancer cells can become addicted to specific oncogenes like epidermal growth factor receptor (EGFR). This study dissects EGFR addiction, revealing key structural features and surprising signaling requirements for cancer cell survival.

More Related Videos

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Published on: October 16, 2017

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Experiment Videos

Last Updated: Jul 2, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Published on: October 16, 2017

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Selective kinase inhibitors highlight cancer cell dependence on single oncogenes, termed "oncogene addiction."
RNA interference (RNAi) is used to study oncogene addiction but suffers from off-target effects.
Understanding oncogene addiction is crucial for identifying and validating new cancer therapeutic targets.

Purpose of the Study:

To rigorously analyze the structural features and signaling activities determining addiction to mutationally activated epidermal growth factor receptor (EGFR) in human lung cancer.
To overcome limitations of RNAi by combining short hairpin RNA (shRNA) knockdown with heterologous reconstitution.
To dissect the mechanisms of oncogene addiction through quantitative "oncogene rescue" analysis.

Main Methods:

Lentiviral-mediated short hairpin RNA (shRNA) knockdown of epidermal growth factor receptor (EGFR).
Heterologous reconstitution of EGFR by specific EGFR mutants.
Quantitative "oncogene rescue" analysis to assess EGFR dependence.

Main Results:

EGFR dependence is differentially rescued by various EGFR variants and oncogenic mutants.
EGFR addiction critically depends on its heterodimerization partner, ErbB-3.
Surprisingly, EGFR addiction does not require autophosphorylation sites in the cytoplasmic domain.

Conclusions:

Quantitative "oncogene rescue" analysis provides a robust method for mechanistic dissection of oncogene addiction.
This approach can functionally validate potential therapeutic targets identified through large-scale RNAi screens.
Findings offer insights into the specific requirements for EGFR addiction in lung cancer, guiding targeted therapy development.